# Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/LQDA/liquidia-corporation-to-present-at-44th-annual-j-p-morgan-healthcare-conference
Ticker: LQDA
Company: Liquidia Corporation
Source: Liquidia Corporation
Published: 2026-01-07 12:00 EST
Original Source URL: https://www.liquidia.com
## Summary

MORRISVILLE, N.C. , Jan. 07, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Dr. Roger Jeffs , Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 beginning at approximately 5:15 p.m.

## Article Body
MORRISVILLE, N.C. , Jan. 07, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Dr. Roger Jeffs , Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 beginning at approximately 5:15 p.m.
## Recent Company News
- 2026-05-27 12:30 EST — [Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/LQDA/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference) — Source: Liquidia Corporation
- 2026-05-11 10:30 EST — [Liquidia Corporation Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/LQDA/liquidia-corporation-reports-first-quarter-2026-financial-results) — Source: Liquidia Corporation
- 2026-05-06 12:30 EST — [Liquidia Corporation to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/LQDA/liquidia-corporation-to-participate-in-upcoming-investor-conferences) — Source: Liquidia Corporation
- 2026-05-04 12:30 EST — [Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026](https://biopharmsignal.com/news/LQDA/liquidia-corporation-to-report-first-quarter-2026-financial-results-on-may-11-2026) — Source: Liquidia Corporation
- 2026-03-05 11:30 EST — [Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update](https://biopharmsignal.com/news/LQDA/liquidia-corporation-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-business-update) — Source: Liquidia Corporation
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)